Table 5-23Electrical stimulation plus PFMT vs. Control – Clinical study characteristics

OutcomeNumber of studiesDesignLimitationsInconsistencyIndirectnessImprecision
Incontinence at 0 - 3 months follow up203,3212RCT (a)Serious limitations (b)No serious inconsistencyNo serious indirectness (c)Serious imprecision (d)
Incontinence at 3 - 6 months follow up0
Incontinence at 6 - 12 months follow up3211RCT (a)Serious limitations (b)No serious inconsistencyNo serious indirectness (c)Serious imprecision (d)
Quality of life (IPSS question)0
Adverse events0

Studies are supplemented by data from the Cochrane systematic reviews Hunter 2007123


Both studies report randomisation method and allocation concealment but neither study reports masked outcome assessment and there was serious attrition from one study321. Although there is no statistical heterogeneity, differences between studies are noted in timing, intensity and duration of sessions, treatment duration and amount of supplementary written and verbal information provided.


All patients underwent prostatectomy for localised prostate cancer and are likely to experience more severe incontinence as a result of surgery compared to men with overactive bladder or those following a TURP. However this is unlikely to significantly reduce the applicability of the results.


Confidence intervals cross MID making estimate of effect uncertain.

From: 5, Conservative management for men with lower urinary tract symptoms

Cover of The Management of Lower Urinary Tract Symptoms in Men
The Management of Lower Urinary Tract Symptoms in Men [Internet].
NICE Clinical Guidelines, No. 97.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.